• 제목/요약/키워드: Medical products

검색결과 1,278건 처리시간 0.033초

Effect of Active Synthetic 2-Substituted Quinazolinones on Anti-Platelet Aggregation and the Inhibition of Superoxide Anion Generation by Neutrophils

  • Chang, Fang-Rong;Wu, Chin-Chung;Hwang, Tsong-Long;Patnam, Ramesh;Kuo, Reen-Yen;Wang, Wei-Ya;Lan, Yu-Hsuan;Wu, Yang-Chang
    • Archives of Pharmacal Research
    • /
    • 제26권7호
    • /
    • pp.511-515
    • /
    • 2003
  • Quinazolinones, 2-substituted and 3-substituted, mainly synthesized by microwave irradiation, were subjected to anti-platelet aggregation and inhibition of superoxide anion generation assays. Interestingly, 2-phenyl-4-quinazolinone (4) exhibited significant inhibitory activities toward platelet aggregation and neutrophil activation, and it might therefore serve as a prototype lead compound.

의료용(醫療用) 방사성폐기물(放射性廢棄物)의 관리현황(管理現況) (A Study on Control Status of Radioactive Waste Products in Medical Institution)

  • 김창균;김유현
    • 대한방사선기술학회지:방사선기술과학
    • /
    • 제18권1호
    • /
    • pp.81-90
    • /
    • 1995
  • This study was conducted to find out the management status of radioisotopes and radioactive waste products in Korean medical institutions during the period of three years from 1991 to 1993. The results are summarized as follows : 1. The rate of medical institution to the institutions making use of radioisotopes was decreased every year, for example, 18.11 % in the year 1991, 17.86 % in the year 1992 and 15.87 % in the year 1993. 2. The use of domestic made radioisotopes in the medical institution was increased every year, for instance, 89.68 % in the year 1991, 94.21 % in the year 1992 and 99.79 % in the year 1993. 3. 91.01 % of the half life of isotopes used in the medical Institution were two month below. 4. The rate of radioactive waste products in the medical institution to all radioactive waste products was increased every year, for example, 54.44 % in the year 1991, 75.36 % in 1992 and 78.49 % in the year 1993. 5. The rate of inflammable waste products from medical institution was 76.47 % of all inflammable waste products, and 73.99 % of whole waste products was from the medical Institution.

  • PDF

일본인 관광객의 의료관광상품 선호도 영향요인 분석 (Influencing Factors to Preference of Medical Tourism Products of Japanese Tourists)

  • 윤성용;이재국;류시원
    • 한국병원경영학회지
    • /
    • 제15권4호
    • /
    • pp.165-190
    • /
    • 2010
  • Objectives : This study was supposed to investigate factors which influence to preference of medical tourism products of Japanese tourists in Seoul, Korea. Methods : Data were collected from 228 Japanese tourists who visited' Seoul Center for Culture & Tourism' in Myeong-dong, Seoul, Korea. We measured factors which influence to preference for medical tourism. The data were analyzed by T-test, ANOVA, and multiple regression analysis. Results : The major findings were as follows ; Japanese tourists preferred medical products in the order of skin care, oriental medicine treatment, health screening, and scaling & teeth whitening. They considered technical level of medical staff most importantly, followed by safety of medical products, communication during diagnosis and treatment, follow-up service, modernization of medical facilities and equipment, and the reasonable medical expenses. Japanese tourists' preferred medical institutions in the order of a university hospital, a specialty clinic, a special hospital, They said they intend to pay 50,000 to 150,000 yen for medical tourism. The preference to medical tourism products are that single women group in their twenties and thirties for skin care, married people group aged over thirties preferred oriental medicine treatment, and married men aged over forties and high income earners favored health screening. Conclusions : It should be considered carefully that the preference exists on some factors especially for Japanese tourist. Further research about preference on medical tourism products for tourists from the other countries is required appropriately to fulfill the needs.

  • PDF

Chemical Constituents from the Hydrangea chinensis

  • Khalil, Ashraf-Taha;Chang, Fang-Rong;Lee, Yue-Han;Chen, Chung-Yi;Liaw, Chih-Chuang;Patnam Ramesh;Shyng Shiou F.Yuan;Wu, Yang-Chang
    • Archives of Pharmacal Research
    • /
    • 제26권1호
    • /
    • pp.15-20
    • /
    • 2003
  • Two quinazolone alkaloids, (+)-febrifugine (1) and isofebrifugine (2), along with three coumarin derivatives, 6-hydroxy coumarin (3), skimmin (5), and $umbelliferone-7-O-{\alpha}-L-rhamnopyranosyl(1{\rightarrow}4)-{\beta}-D-glucopyranoside$ (6), were isolated from the roots of Hydrangea chinensis. Compound 6 is a new compound. In addition, umbelliferone (4), linoleic acid (7), two steroidal glycosides (8, 9), three furfural derivatives (10-12), and butyl-$\beta$-D-fructofuranoside (13) were isolated from the leaves of the same plant. The structures of all isolates were elucidated by spectral methods.

의약품 관련 법규상 개념 정의의 시행연혁에 관한 소고 (A Study on the Changes in Legal Definition of Medicinal Products in the Relevant Laws and Regulations)

  • 엄석기
    • 대한예방한의학회지
    • /
    • 제18권1호
    • /
    • pp.23-41
    • /
    • 2014
  • Objective : The purpose of this study was to lay the groundwork for understanding the details and scope of the legal definition of medicinal products, following the changes in the relevant laws and regulations. This will let readers properly understand the origins of the ongoing conflicts on herbal drugs and new drugs from natural products that are present in the medical field and the medical industry. Possible solutions are proposed in the end. Method : I analyzed the changes in definition of medicinal products since 1945 that have been used in relevant laws and regulations(i.e. Pharmaceutical Affairs Act) and drug approval process(i.e. New Drug Application and Investigational New Drug Application). Results : Legal definition of medicinal products has changed in accordance with the changes in the pharmaceutical industry, such as the establishment of dualistic medical and pharmaceutical System and the introduction of the substance patent. Due to those changes, boundaries of Western medicinal products and health food expanded, while those of herbal medicine products relatively downscaled. Conclusion : Legal definition of medicinal products-i.e. Herbal Drugs, Crude Drugs, and New Drugs from Natural Products-should be reestablished according to academic legitimacy and dualistic medical and pharmaceutical System.

주요국의 혁신적 의료기기 관리제도에 대한 비교 연구 (A Comparative Study on Innovative Medical Device Management Systems in Major Countries)

  • 이진수;김수경
    • 대한의용생체공학회:의공학회지
    • /
    • 제43권3호
    • /
    • pp.153-160
    • /
    • 2022
  • As new types of medical devices are emerging through convergence with advanced technology, innovative technologies are becoming hot issues in health policy because of their disruptiveness. This study analyzed the innovative medical device management systems in the US, China and Korea. Innovative medical devices have been defined differently depending on the country's management system, but in common, they are defined as products that do not exist or have dramatically improved performance compare to existing products by applying innovative technologies. Innovative medical devices have been supported by regulatory authorities during product development and approval processes. While the US and China have more than 300 products designated as innovative medical devices with diverse functions, application fields, and manufacturing countries considering the initial situation of the implementation for the system, Korea has only 16 products, mainly radiology and diagnostic devices and made in Korea only as innovative medical device. In addition, Korea shows the highest market approval rate of innovative medical devices compare to the US and China, and it is necessary to prepare the approval process in consideration of product diversity.

Modulation of dendritic cell function by Trichomonas vaginalis-derived secretory products

  • Song, Min-Ji;Lee, Jong-Joo;Nam, Young Hee;Kim, Tae-Gyun;Chung, Youn Wook;Kim, Mikyoung;Choi, Ye-Eun;Shin, Myeong Heon;Kim, Hyoung-Pyo
    • BMB Reports
    • /
    • 제48권2호
    • /
    • pp.103-108
    • /
    • 2015
  • Trichomoniasis caused by the parasitic protozoan Trichomonas vaginalis is the most common sexually transmitted disease in the world. Dendritic cells are antigen presenting cells that initiate immune responses by directing the activation and differentiation of naive T cells. In this study, we analyzed the effect of Trichomonas vaginalis-derived Secretory Products on the differentiation and function of dendritic cells. Differentiation of bone marrow-derived dendritic cells in the presence of T. vaginalis-derived Secretory Products resulted in inhibition of lipopolysaccharide-induced maturation of dendritic cells, down-regulation of IL-12, and up-regulation of IL-10. The protein components of T. vaginalis-derived Secretory Products were shown to be responsible for altered function of bone marrow-derived dendritic cells. Chromatin immunoprecipitation assay demonstrated that IL-12 expression was regulated at the chromatin level in T. vaginalis-derived Secretory Products-treated dendritic cells. Our results demonstrated that T. vaginalis- derived Secretory Products modulate the maturation and cytokine production of dendritic cells leading to immune tolerance.

제조물책임법상 제조물로서 의약품의 결함 (Defective Medicine according to Product Liability Law)

  • 전병남
    • 의료법학
    • /
    • 제8권1호
    • /
    • pp.235-277
    • /
    • 2007
  • In Product Liability law, the 'defection' of the manufactured products is its key concept, defined in detail. The concept had been already developed through the precedents and theories for the past years even before the PL law was enacted and the concept was listed. Especially, the medicine products need the different approach, because they might directly harm to the human life and body due to their being injected or taken, unlikely other manufactured articles. Since the medical products have the double contradictory functions such as effects and side effects, the defection decisions become so difficult. However, because there are high concerns that wrong medical products will directly harm the human life and body, the decision standards should be more strengthened. The decision standards should include the risk-effect standard as the considered components and make the customer-expecting standard as the final standard. The decision time for defection should be made considering the science technology level when the medical products were provided, not when the accident occurred. It is the most important for the manufacturers to prevent the damages by making and selling the non-defective medicine products for themselves, rather than by taking the legal remedy means afterwards. Therefore, the non-defective guidelines for the medicine manufacturers will help increase the effects and minimize the side-effects.

  • PDF

전리방사선을 이용한 의료제품 멸균연구 (Radiosterilization of Medical Products)

  • 민봉희;천기정;이강순
    • 미생물학회지
    • /
    • 제11권4호
    • /
    • pp.181-188
    • /
    • 1973
  • For the bulk sterilization, there are two traditional methods of autoclaving and exposure to ethylene oxide. However, autoclaving involves high temperatures and pressures and ethylene oxide is chemically highly reactive, so these methods are radiation, we have carried out sterility and safety tests on some medical products irradiated at varying radiation levels. The results obtained were as follows ; 1) The minimum dose of radiation for the sterilization of medical products was 2.5 Mrad. 2) The radiosterilization dose varied depending on the initial population of microorganisms. 3) In transfusion sets, a level of radiation of 2.5Mrad at room temperature produced no pyrogen and they remained bacteriologically sterile.

  • PDF